193 related articles for article (PubMed ID: 23931215)
1. Re: Inhaled anticholinergic agents and acute urinary retention in men with lower urinary tract symptoms or benign prostatic hyperplasia.
Kaplan SA
J Urol; 2013 Sep; 190(3):979. PubMed ID: 23931215
[No Abstract] [Full Text] [Related]
2. Inhaled anticholinergic agents and acute urinary retention in men with lower urinary tract symptoms or benign prostatic hyperplasia.
Vande Griend JP; Linnebur SA
Ann Pharmacother; 2012 Sep; 46(9):1245-9. PubMed ID: 22851743
[TBL] [Abstract][Full Text] [Related]
3. Does anticholinergic medication have a role in treating men with overactive bladder and benign prostatic hyperplasia?
Lee KS; Lee HW; Han DH
Naunyn Schmiedebergs Arch Pharmacol; 2008 Jun; 377(4-6):491-501. PubMed ID: 18172610
[TBL] [Abstract][Full Text] [Related]
4. Inhaled anticholinergic drugs and risk of acute urinary retention.
Afonso AS; Verhamme KM; Stricker BH; Sturkenboom MC; Brusselle GG
BJU Int; 2011 Apr; 107(8):1265-72. PubMed ID: 20880196
[TBL] [Abstract][Full Text] [Related]
5. [Benign prostatic obstruction-associated symptoms of the lower urinary tract : Treatment with anticholinergics in combination with alpha-blockers].
Schönburg S
Urologe A; 2021 Sep; 60(9):1188-1191. PubMed ID: 34357409
[No Abstract] [Full Text] [Related]
6. Chronic Prostate Inflammation is Associated with Severity and Progression of Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms and Risk of Acute Urinary Retention.
Nickel JC; Roehrborn CG; Castro-Santamaria R; Freedland SJ; Moreira DM
J Urol; 2016 Nov; 196(5):1493-1498. PubMed ID: 27378134
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Initial Combination Treatment of an Alpha Blocker with an Anticholinergic Medication in Benign Prostatic Hyperplasia Patients with Lower Urinary Tract Symptoms: Updated Meta-Analysis.
Kim HJ; Sun HY; Choi H; Park JY; Bae JH; Doo SW; Yang WJ; Song YS; Ko YM; Kim JH
PLoS One; 2017; 12(1):e0169248. PubMed ID: 28072862
[TBL] [Abstract][Full Text] [Related]
8. Re: Twelve-Month Medication Persistence in Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia.
Kaplan SA
J Urol; 2015 Oct; 194(4):1056. PubMed ID: 26382807
[No Abstract] [Full Text] [Related]
9. Long-term safety and efficacy of single-tablet combinations of solifenacin and tamsulosin oral controlled absorption system in men with storage and voiding lower urinary tract symptoms: results from the NEPTUNE Study and NEPTUNE II open-label extension.
Drake MJ; Chapple C; Sokol R; Oelke M; Traudtner K; Klaver M; Drogendijk T; Van Kerrebroeck P;
Eur Urol; 2015 Feb; 67(2):262-70. PubMed ID: 25070148
[TBL] [Abstract][Full Text] [Related]
10. The evolving picture of lower urinary tract symptom management.
Tubaro A; De Nunzio C; Puccini F; Presicce F
Eur Urol; 2015 Feb; 67(2):271-2. PubMed ID: 25457016
[No Abstract] [Full Text] [Related]
11. Anticholinergic therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia.
Gallegos PJ; Frazee LA
Pharmacotherapy; 2008 Mar; 28(3):356-65. PubMed ID: 18294115
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of the coadministration of tadalafil once daily with finasteride for 6 months in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia.
Casabé A; Roehrborn CG; Da Pozzo LF; Zepeda S; Henderson RJ; Sorsaburu S; Henneges C; Wong DG; Viktrup L
J Urol; 2014 Mar; 191(3):727-33. PubMed ID: 24096118
[TBL] [Abstract][Full Text] [Related]
13. Response to daily 10 mg alfuzosin predicts acute urinary retention and benign prostatic hyperplasia related surgery in men with lower urinary tract symptoms.
Emberton M; Lukacs B; Matzkin H; Alcaraz A; Elhilali M; Vallancien G
J Urol; 2006 Sep; 176(3):1051-6. PubMed ID: 16890690
[TBL] [Abstract][Full Text] [Related]
14. Direct effects of tadalafil on lower urinary tract symptoms versus indirect effects mediated through erectile dysfunction symptom improvement: integrated data analyses from 4 placebo controlled clinical studies.
Brock GB; McVary KT; Roehrborn CG; Watts S; Ni X; Viktrup L; Wong DG; Donatucci C
J Urol; 2014 Feb; 191(2):405-11. PubMed ID: 24096120
[TBL] [Abstract][Full Text] [Related]
15. Change in sexual function in men with lower urinary tract symptoms/benign prostatic hyperplasia associated with long-term treatment with doxazosin, finasteride and combined therapy.
Fwu CW; Eggers PW; Kirkali Z; McVary KT; Burrows PK; Kusek JW
J Urol; 2014 Jun; 191(6):1828-34. PubMed ID: 24342143
[TBL] [Abstract][Full Text] [Related]
16. Re: tadalafil once daily for lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a randomized placebo- and tamsulosin-controlled 12-week study in asian men.
Kaplan SA
J Urol; 2014 May; 191(5):1345. PubMed ID: 24745512
[No Abstract] [Full Text] [Related]
17. [Medical therapy of male lower urinary tract symptoms].
Gratzke C; Stief CG
Urologe A; 2013 Feb; 52(2):184-5. PubMed ID: 23370400
[No Abstract] [Full Text] [Related]
18. Re: Drug Adherence and Clinical Outcomes for Patients Under Pharmacological Therapy for Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia: Population-based Cohort Study.
Gravas S
Eur Urol; 2015 Aug; 68(2):338-9. PubMed ID: 26149729
[No Abstract] [Full Text] [Related]
19. Benign prostatic hyperplasia and lower urinary tract symptoms.
Cornu JN; Oelke M; Parsons KF
N Engl J Med; 2012 Oct; 367(17):1668; author reply 1668-9. PubMed ID: 23094741
[No Abstract] [Full Text] [Related]
20. Evaluation and validation of the core lower urinary tract symptom score as an outcome assessment tool for the treatment of benign prostatic hyperplasia: effects of the α1-adrenoreceptor antagonist silodosin.
Ito H; Sano F; Ogawa T; Yao M
Int J Urol; 2014 Jan; 21(1):108-12. PubMed ID: 23662900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
